Collegium Pharmaceutical (FRA:354) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Collegium Pharmaceutical Cash Flow for Lease Financing?

Collegium Pharmaceutical's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was €0.0 Mil. Collegium Pharmaceutical's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Dec. 2024 ), Collegium Pharmaceutical's Cash Flow for Lease Financing remained the same in Mar. 2025 (€0.0 Mil).

Collegium Pharmaceutical Cash Flow for Lease Financing Historical Data

The historical data trend for Collegium Pharmaceutical's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical Cash Flow for Lease Financing Chart

Collegium Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Collegium Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-	-	-	-	-

Collegium Pharmaceutical Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Collegium Pharmaceutical Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Collegium Pharmaceutical's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Collegium Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (FRA:354) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

COLL:USA

Address

100 Technology Center Drive, Stoughton, MA, USA, 02072

Website

https://www.collegiumpharma.com

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical Headlines

No Headlines